ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, and the American Cancer Society, a leading cancer-fighting organization, announce a new...
Artera, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, announced new data at ASCO GU 2023 demonstrating that its multimodal artificial intelligence...
